Christine has worked at the forefront of healthcare innovation since the beginning of her career at Roche and has been in venture capital since 2011. As a founder, business executive and investor, Christine evaluates companies through a unique lens, making her an invaluable resource for entrepreneurs.

At Roche, Christine launched the revolutionary technology polymerase chain reaction (PCR), formed the first cross collaboration between the pharmaceutical and diagnostic divisions, and was placed on the Executive Development Track. At Sanofi in the Advance Therapeutics and Oncology Division she launched four drugs. Christine then moved to Silicon Valley and transitioned to the startup world, working with new technology platform companies, including Genomic Health. 

She has a proven track record of investing in sector leaders, and her meaningful relationships and expertise span pharmaceuticals, diagnostics, genomics, technology, and finance. She has launched more than 20 products in the pharmaceutical, genomics, healthcare technology and diagnostic sectors.

Prior to founding Magnetic, Christine was a Managing Director at Foresite Capital, which she joined at its founding. She was instrumental in building the firm from zero to $1.2 billion in assets under management and helped identify and grow some of the most valuable companies within the portfolio. Christine has also been an entrepreneur in the media sector and was a partner at a technology-focused investment bank acquired by Goldman Sachs. Christine currently sits on the Boards of Relation Therapeutics, Weave Bio, Terrain Bio, and Amydis, and is a member of the Biopharm Advisory Council for Washington University School of Medicine.